Projects per year
Personal profile
Expertise
- Master of Science in Drug Development (2011-2016)
- PhD in Pharmaceutical Sciences (2016 - present)
- FWO PhD fellowship (2016 - 2020)
- PhD fellowship (2020 - ...)
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
VLAIM5: Innovation mandate Spin-off: EVOZymes Development Platform
Neuckermans, J., De Kock, J. & Vanhaecke, T.
1/08/23 → 31/07/25
Project: Applied
-
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
Neuckermans, J., Lequeue, S., Claes, P., Heymans, A., Hughes, J. H., Colemonts-Vroninks, H., Marcélis, L., Casimir, G., Goyens, P., Martens, G. A., Gallagher, J. A., Vanhaecke, T., Bou-Gharios, G. & De Kock, J., 11 Mar 2023, In: Genes. 14, 3, 15 p., 693.Research output: Contribution to journal › Article › peer-review
Open Access -
A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria
Lequeue, S., Neuckermans, J., Nulmans, I., Schwaneberg, U., Vanhaecke, T. & De Kock, J., 14 Nov 2022, In: Scientific Reports. 12, 1, p. 1-15 15 p., 19452.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)10 Downloads (Pure) -
Development of a robust high-throughput screening system for the evaluation of human homogentisate 1,2-dioxygenase missense variants in the context of rare disease alkaptonuria
Lequeue, S., Neuckermans, J., Vanhaecke, T. & De Kock, J., 2022.Research output: Unpublished contribution to conference › Poster
-
Development of a robust high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of rare disease alkaptonuria
Lequeue, S., Neuckermans, J., Vanhaecke, T. & De Kock, J., 2022.Research output: Unpublished contribution to conference › Poster
Open Access -
High-throughput quantification of ochronotic pigment formation in Escherichia coli to evaluate the potency of human 4-hydroxyphenylpyruvate dioxygenase inhibitors in multi-well format
Neuckermans, J., Lequeue, S., Mertens, A., Branson, S., Schwaneberg, U. & De Kock, J., Jan 2021, In: MethodsX. 8, 11 p., 101181.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)49 Downloads (Pure)
Activities
-
World Orphan Drugs Rare Disease Day
Jessie Neuckermans (Participant)
2 Mar 2021Activity: Participating in or organising an event › Participation in conference
-
LSM PHD DAY
Jessie Neuckermans (Participant)
30 Mar 2021Activity: Participating in or organising an event › Participation in conference
-
World Advanced Therapies & Regenerative Medicine 2021
Jessie Neuckermans (Participant)
1 Apr 2021 → 3 Apr 2021Activity: Participating in or organising an event › Participation in conference
-
Visiting researcher at the University of Liverpool - Institute of Ageing and Chronic Disease
Jessie Neuckermans (Visitor)
16 Mar 2020 → 27 Mar 2020Activity: Other › Research and Teaching at External Organisation
-
World Advanced Therapies and Regenerative medicine 2020
Jessie Neuckermans (Participant)
7 Sep 2020 → 9 Sep 2020Activity: Participating in or organising an event › Participation in conference
Thesis
-
Bepaling van het optimale mRNA elektroporatieprotocol voor humane huidafgeleide stamcellen.
Author: Neuckermans, J. & Vanhaecke, T., 2016Student thesis: Master's Thesis
-
Establishment of the optimal mRNA electroporation protocol for human skin-derived stem cells
Author: Neuckermans, J. & De Kock, J., 2016Supervisor: De Kock, J. (Promotor)
Student thesis: Master's Thesis
-
Evaluatie van de efficiëntie van CRE mRNA-geïnduceerde recombinase in humane huidafgeleide mesenchymale stamcellen.
Author: Rombaut, M., Vanhaecke, T., De Kock, J. & Neuckermans, J., 2018Supervisor: Vanhaecke, T. (Promotor)
Student thesis: Master's Thesis